You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment

Article metrics

Article menu
XML
Basic tumor immunology
Original research
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment

 

Online download statistics by month:

Online download statistics by month: May 2021 to July 2025

AbstractFullPdf
May 202122322392
Jun 2021397398187
Jul 202116316347
Aug 202113413441
Sep 202111411444
Oct 202110110144
Nov 202111311362
Dec 202113413739
Jan 2022889129
Feb 202210510639
Mar 2022757933
Apr 2022869245
May 2022838735
Jun 2022889026
Jul 2022868738
Aug 2022727218
Sep 2022838432
Oct 2022949835
Nov 2022707020
Dec 2022757524
Jan 2023666713
Feb 202310110230
Mar 2023616540
Apr 2023525416
May 2023585929
Jun 2023545421
Jul 2023889034
Aug 2023747420
Sep 2023818129
Oct 2023616417
Nov 2023636419
Dec 2023495024
Jan 2024394032
Feb 2024484842
Mar 2024858676
Apr 2024757523
May 2024666623
Jun 2024929119
Jul 2024929327
Aug 2024555319
Sep 2024787938
Oct 2024919135
Nov 2024868741
Dec 20248789133
Jan 202510310340
Feb 2025828250
Mar 2025838360
Apr 202510710779
May 2025686946
Jun 2025373721
Jul 2025220
Total456846192026